Bavarian Nordic A/S (BAVA.CO)
BAVA.CO on Copenhagen Stock Exchange
179.35DKK
9:01am BST
179.35DKK
9:01am BST
Change (% chg)
kr.0.35 (+0.20%)
kr.0.35 (+0.20%)
Prev Close
kr.179.00
kr.179.00
Open
kr.179.15
kr.179.15
Day's High
kr.179.75
kr.179.75
Day's Low
kr.177.95
kr.177.95
Volume
9,103
9,103
Avg. Vol
148,531
148,531
52-wk High
kr.202.80
kr.202.80
52-wk Low
kr.117.75
kr.117.75
About
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate... (more)
Overall
| Beta: | 1.55 |
| Market Cap(Mil.): | kr.5,785.38 |
| Shares Outstanding(Mil.): | 32.32 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| BAVA.CO | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 30.33 | 34.23 |
| EPS (TTM): | -8.68 | -- | -- |
| ROI: | -10.59 | 12.99 | 12.65 |
| ROE: | -12.63 | 14.18 | 17.19 |
BRIEF-Bavarian Nordic REPORTS Positive Result From Phase 2 Trial Evaluating BN-Brachyury In Chordoma
* REPORTED ON WEDNESDAY POSITIVE RESULT FROM ONGOING PHASE 2 TRIAL EVALUATING BN-BRACHYURY IN CHORDOMA
Estimates